BMY
Bristol-Myers Squibb Company
NYQ
$54.46
-0.49
(-0.89%)
Pullback · -1.94σ
Grade C
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$111.2B
P/E ttm
15.3
Fwd P/E
8.8
Beta
0.26
Day range
$54.46
52w range
$49.43 – $62.89
Avg vol
11.6M
RSI(2)
4.3
ROE
38.7%
Net mgn
15.0%
FCF mgn
20.3%
Debt/Eq
2.31
Div yld
459.00%
Sector
Healthcare
Industry
Drug Manufacturers - General
Next earn
2026-07-30
Matrix setup grades
Long
C
score 28 · tech 28 / 80 · support 0 / 20
KC2 lower, -1.94 ATR from EMA21 · no notable pattern
- · KC2 lower stretch — standard mean-reversion tier
- · Aligned with weak uptrend
Short
—
score 24 · tech 24 / 80 · support 0 / 20
below KC1 upper, -1.94 ATR from EMA21 · shooting star
- · Shooting star — long upper wick rejection
Options · swing
See more →
CALL
$55
2026-07-17
$1.82
PUT
$55
2026-07-17
$2.63
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-30
- EPS (act / est)
- 1.31 / 1.15
- Surprise
- +13.9%
- Next report
- 2026-07-30
About
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid t…